These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 7908268

  • 1. Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group.
    van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Kerrebijn KF.
    Eur Respir J; 1994 Jan; 7(1):63-8. PubMed ID: 7908268
    [Abstract] [Full Text] [Related]

  • 2. Long-term intervention in childhood asthma: the Dutch study results. Dutch Chronic Nonspecific Lung Disease Study Group.
    van Essen-Zandvliet EE.
    Monaldi Arch Chest Dis; 1995 May; 50(3):201-7. PubMed ID: 7663491
    [Abstract] [Full Text] [Related]

  • 3. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group.
    Waalkens HJ, Van Essen-Zandvliet EE, Hughes MD, Gerritsen J, Duiverman EJ, Knol K, Kerrebijn KF.
    Am Rev Respir Dis; 1993 Nov; 148(5):1252-7. PubMed ID: 8239161
    [Abstract] [Full Text] [Related]

  • 4. The effect of an inhaled corticosteroid (budesonide) on exercise-induced asthma in children. Dutch CNSLD Study Group.
    Waalkens HJ, van Essen-Zandvliet EE, Gerritsen J, Duiverman EJ, Kerrebijn KF, Knol K.
    Eur Respir J; 1993 May; 6(5):652-6. PubMed ID: 8519374
    [Abstract] [Full Text] [Related]

  • 5. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group.
    van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF.
    Am Rev Respir Dis; 1992 Sep; 146(3):547-54. PubMed ID: 1355640
    [Abstract] [Full Text] [Related]

  • 6. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
    Cockcroft DW, Swystun VA, Bhagat R.
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
    [Abstract] [Full Text] [Related]

  • 7. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma.
    Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O.
    N Engl J Med; 1991 Aug 08; 325(6):388-92. PubMed ID: 2062329
    [Abstract] [Full Text] [Related]

  • 8. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW, van der Mark TW, Koëter GH, Postma DS.
    Am J Respir Crit Care Med; 1996 Jan 08; 153(1):70-5. PubMed ID: 8542165
    [Abstract] [Full Text] [Related]

  • 9. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group.
    Brand PL, Duiverman EJ, Waalkens HJ, van Essen-Zandvliet EE, Kerrebijn KF.
    Thorax; 1999 Feb 08; 54(2):103-7. PubMed ID: 10325912
    [Abstract] [Full Text] [Related]

  • 10. Effect of regular terbutaline on the airway response to inhaled budesonide.
    Wilding PJ, Clark MM, Oborne J, Bennett JA, Tattersfield AE.
    Thorax; 1996 Oct 08; 51(10):989-92. PubMed ID: 8977598
    [Abstract] [Full Text] [Related]

  • 11. Acute effect of sodium cromoglycate on airway narrowing induced by 4.5 percent saline aerosol. Outcome before and during treatment with aerosol corticosteroids in patients with asthma.
    Anderson SD, du Toit JI, Rodwell LT, Jenkins CR.
    Chest; 1994 Mar 08; 105(3):673-80. PubMed ID: 8131524
    [Abstract] [Full Text] [Related]

  • 12. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma.
    Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE.
    Am Rev Respir Dis; 1991 Jun 08; 143(6):1317-21. PubMed ID: 2048819
    [Abstract] [Full Text] [Related]

  • 13. Minor acute effect of an inhaled corticosteroid (budesonide) on bronchial hyperresponsiveness to methacholine in children with asthma.
    van Essen-Zandvliet EE, Hop WC, de Jong H, Ferwerda A, Kerrebijn KF.
    Eur Respir J; 1993 Mar 08; 6(3):383-6. PubMed ID: 8472829
    [Abstract] [Full Text] [Related]

  • 14. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma.
    Weiner P, Weiner M, Azgad Y.
    Thorax; 1995 Dec 08; 50(12):1270-3. PubMed ID: 8553300
    [Abstract] [Full Text] [Related]

  • 15. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH, Kharitonov SA, Barnes PJ.
    Am J Respir Crit Care Med; 1996 Dec 08; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial.
    Laitinen LA, Laitinen A, Haahtela T.
    J Allergy Clin Immunol; 1992 Jul 08; 90(1):32-42. PubMed ID: 1629507
    [Abstract] [Full Text] [Related]

  • 17. Does ketotifen have a steroid-sparing effect in childhood asthma?
    Canny GJ, Reisman J, Levison H.
    Eur Respir J; 1997 Jan 08; 10(1):65-70. PubMed ID: 9032494
    [Abstract] [Full Text] [Related]

  • 18. Increased inhaled bronchodilator vs increased inhaled corticosteroid in the control of moderate asthma.
    Sears MR, Taylor DR, Print CG, Lake DC, Herbison GP, Flannery EM.
    Chest; 1992 Dec 08; 102(6):1709-15. PubMed ID: 1446477
    [Abstract] [Full Text] [Related]

  • 19. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S, Swystun VA, Bhagat R, Cockcroft DW.
    Chest; 1996 Apr 08; 109(4):953-6. PubMed ID: 8635376
    [Abstract] [Full Text] [Related]

  • 20. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.
    Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijärvi A.
    N Engl J Med; 1994 Sep 15; 331(11):700-5. PubMed ID: 8058076
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.